Ze‐Ya Pan

2.8k total citations
55 papers, 2.1k citations indexed

About

Ze‐Ya Pan is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Ze‐Ya Pan has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 20 papers in Surgery and 18 papers in Epidemiology. Recurrent topics in Ze‐Ya Pan's work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Liver Disease Diagnosis and Treatment (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Ze‐Ya Pan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Liver Disease Diagnosis and Treatment (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Ze‐Ya Pan collaborates with scholars based in China, Hong Kong and United States. Ze‐Ya Pan's co-authors include Weiping Zhou, Wan Yee Lau, Yuan Yang, Mengchao Wu, Eric C. H. Lai, Gang Huang, Siyuan Fu, Aijun Li, Weiping Zhou and Shengxian Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Annals of Surgery.

In The Last Decade

Ze‐Ya Pan

54 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ze‐Ya Pan China 23 1.2k 728 486 482 478 55 2.1k
Jiliang Qiu China 21 655 0.6× 351 0.5× 525 1.1× 255 0.5× 345 0.7× 65 1.5k
Ningling Ge China 20 708 0.6× 328 0.5× 323 0.7× 270 0.6× 505 1.1× 44 1.4k
Hyungjin Rhee South Korea 27 1.1k 0.9× 604 0.8× 289 0.6× 481 1.0× 381 0.8× 66 1.8k
Stefania Brozzetti Italy 21 337 0.3× 343 0.5× 586 1.2× 424 0.9× 468 1.0× 50 1.6k
Shunli Shen China 22 480 0.4× 305 0.4× 434 0.9× 336 0.7× 508 1.1× 58 1.4k
Po‐Lin Lai Taiwan 20 495 0.4× 274 0.4× 933 1.9× 239 0.5× 548 1.1× 25 1.7k
Aurélie Hérault France 12 433 0.4× 253 0.3× 808 1.7× 259 0.5× 337 0.7× 15 1.7k
Wei‐Yu Lu United Kingdom 15 1000 0.8× 476 0.7× 476 1.0× 877 1.8× 185 0.4× 32 1.7k
Tong‐Chun Xue China 22 405 0.3× 208 0.3× 466 1.0× 160 0.3× 501 1.0× 41 1.3k
Yong Yi China 27 347 0.3× 285 0.4× 607 1.2× 305 0.6× 905 1.9× 68 2.0k

Countries citing papers authored by Ze‐Ya Pan

Since Specialization
Citations

This map shows the geographic impact of Ze‐Ya Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze‐Ya Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze‐Ya Pan more than expected).

Fields of papers citing papers by Ze‐Ya Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze‐Ya Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze‐Ya Pan. The network helps show where Ze‐Ya Pan may publish in the future.

Co-authorship network of co-authors of Ze‐Ya Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ze‐Ya Pan. A scholar is included among the top collaborators of Ze‐Ya Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze‐Ya Pan. Ze‐Ya Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Jian, Zhenguang Wang, Qi-fei Tao, et al.. (2023). Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study. Frontiers in Immunology. 14. 1198562–1198562. 1 indexed citations
3.
Li, Li, Zhiyun Guo, Juan Wang, et al.. (2022). Primary hepatic paraganglioma mimicking hepatocellular carcinoma: a case report. Translational Cancer Research. 11(9). 3434–3439. 3 indexed citations
4.
Liu, Huiying, Fuchen Liu, Fangming Gu, et al.. (2021). Circulating Tumor Cells Expressing Krüppel-Like Factor 8 and Vimentin as Predictors of Poor Prognosis in Pancreatic Cancer Patients. Cancer Control. 28. 2895445211–2895445211. 12 indexed citations
8.
9.
Wang, Chao, Ming-Da Wang, Cheng Peng, et al.. (2017). Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma. Cell Death and Disease. 8(1). e2560–e2560. 50 indexed citations
10.
Pan, Ze‐Ya, Hào Pān, Jin Zhang, et al.. (2015). Lentivirus mediated silencing of Ubiquitin Specific Peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro. Biological Research. 48(1). 18–18. 20 indexed citations
11.
Wang, Zhenguang, W. Y. Lau, Siyuan Fu, et al.. (2015). Anterior Hepatic Parenchymal Transection for Complete Caudate Lobectomy to Treat Liver Cancer Situated in or Involving the Paracaval Portion of the Caudate Lobe. Journal of Gastrointestinal Surgery. 19(5). 880–886. 8 indexed citations
12.
Yin, Lei, Hui Li, Aijun Li, et al.. (2014). Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT. Journal of Hepatology. 61(1). 82–88. 233 indexed citations
13.
Ni, Jun-sheng, Wan Yee Lau, Yuan Yang, et al.. (2013). A Prospective Randomized Controlled Trial to Compare Pringle Manoeuvre with Hemi-hepatic Vascular Inflow Occlusion in Liver Resection for Hepatocellular Carcinoma with Cirrhosis. Journal of Gastrointestinal Surgery. 17(8). 1414–1421. 24 indexed citations
14.
Huang, Gang, Yuan Yang, Feng Shen, et al.. (2012). Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load. Annals of Surgical Oncology. 20(5). 1482–1490. 32 indexed citations
15.
Huang, Gang, Eric C. H. Lai, Wan Yee Lau, et al.. (2012). Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Annals of Surgery. 257(3). 490–505. 97 indexed citations
16.
Lai, Eric C. H., Hui Liu, Aijun Li, et al.. (2011). Diagnostic difficulties and treatment strategy of hepatic angiomyolipoma. Asian Journal of Surgery. 34(4). 158–162. 11 indexed citations
17.
Yang, Yuan, Tian Yang, Shimin Fu, et al.. (2010). microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. British Journal of Cancer. 103(8). 1215–1220. 218 indexed citations
18.
Fu, Siyuan, Eric C. H. Lai, Aijun Li, et al.. (2009). Liver Resection With Selective Hepatic Vascular Exclusion. Annals of Surgery. 249(4). 624–627. 18 indexed citations
19.
Zhou, Weiping, Eric C. H. Lai, Aijun Li, et al.. (2009). A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma. Annals of Surgery. 249(2). 195–202. 158 indexed citations
20.
Li, Aijun, Ze‐Ya Pan, Weiping Zhou, et al.. (2008). Comparison of Two Methods of Selective Hepatic Vascular Exclusion for Liver Resection Involving the Roots of the Hepatic Veins. Journal of Gastrointestinal Surgery. 12(8). 1383–1390. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026